Viewing Study NCT05987332


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-01-02 @ 2:16 AM
Study NCT ID: NCT05987332
Status: RECRUITING
Last Update Posted: 2025-11-07
First Post: 2023-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
Sponsor: IDEAYA Biosciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module